Literature DB >> 15614151

Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation.

Matteo Ravaioli1, Gian Luca Grazi, Giorgio Ercolani, Michelangelo Fiorentino, Matteo Cescon, Rita Golfieri, Franco Trevisani, Walter Franco Grigioni, Luigi Bolondi, Antonio Daniele Pinna.   

Abstract

BACKGROUND: The presence of partial necrosis in hepatocellular carcinoma (HCC) nodules is a common histologic finding after liver transplantation, but its correlation with tumor recurrence has never been investigated.
METHODS: we retrospectively reviewed the outcome of 54 patients with a single histologically proven HCC after liver transplantation. All cases had a survival of more than 6 months, and patients treated preoperatively had a transarterial chemoembolization (TACE) procedure. Since 1996, our center has applied the Milan criteria. Correlations between tumor recurrences and clinicopathologic variables, including the presence of partial necrosis, were performed. Etiologic factors for HCC partial necrosis were also investigated.
RESULTS: Sixteen of 54 (29.6%) HCC nodules presented partial necrosis, and 4 (25%) of them developed HCC recurrence compared with 1 of 38 (2.6%) cases without this histologic finding (P<0.05). Partial necrosis was related to TACE procedure (P<0.05), patient age less than 50 years (P<0.05), and tumor diameter greater than 2 cm (P<0.05). Multivariate analysis showed only TACE as an independent variable. The other variables related to the five (9.3%) tumor recurrences were HCC diameter greater than 2 cm (P<0.05), year of liver transplantation before 1996 (P<0.05), and the presence of satellite nodules (P<0.05). The Cox regression analysis showed the presence of partial necrosis as an independent variable related to tumor recurrence. The analysis of the recurrence-free survival confirmed the results of the recurrence rate.
CONCLUSION: Partial necrosis was a risk factor for tumor recurrence after liver transplantation. Patients and procedures should be selected while also bearing in mind the side-effect of incomplete necrosis of the nodules.

Entities:  

Mesh:

Year:  2004        PMID: 15614151     DOI: 10.1097/01.tp.0000145892.97114.ee

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  29 in total

1.  Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.

Authors:  Hai-Lin Li; Wen-Bin Ji; Rui Zhao; Wei-Dong Duan; Yong-Wei Chen; Xian-Qiang Wang; Qiang Yu; Ying Luo; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization.

Authors:  Do Young Kim; Moon Seok Choi; Joon Hyoek Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo; Sung Wook Shin; Sung Wook Choo; Young Soo Do; Jong Chul Rhee
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

3.  Neoadjuvant Locoregional Therapy and Recurrent Hepatocellular Carcinoma after Liver Transplantation.

Authors:  Min Xu; Mb Majella Doyle; Babak Banan; Neeta Vachharajani; Xuanchuan Wang; Nael Saad; Kathryn Fowler; Elizabeth M Brunt; Yiing Lin; William C Chapman
Journal:  J Am Coll Surg       Date:  2017-04-09       Impact factor: 6.113

4.  Multi-organ early tumor dissemination after high urgency re-transplantation for hepatocellular carcinoma in cirrhosis: role of massive intraoperative transfusion?

Authors:  Georgios C Sotiropoulos; Susanne Beckebaum; Ernesto P Molmenti; Christian G Klein; Vito R Cicinnati; Christoph E Broelsch; Massimo Malagó
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

Review 5.  The management of patients awaiting liver transplantation.

Authors:  Ka-Kit Li; James Neuberger
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-10-06       Impact factor: 46.802

6.  Criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation.

Authors:  Fei Teng; Gui-Hua Wang; Yi-Feng Tao; Wen-Yuan Guo; Zheng-Xin Wang; Guo-Shan Ding; Xiao-Min Shi; Zhi-Ren Fu
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

7.  Exophytic combined hepatocellular carcinoma and cholangiocarcinoma.

Authors:  Sang Jae Noh; Hyun Kyung Lee; Hee Chul Yu; Woo Sung Moon
Journal:  Clin Mol Hepatol       Date:  2012-12-21

8.  Resection and liver transplantation for HCC.

Authors:  Jacques Belghiti
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

9.  Expression of K19 and K7 in dysplastic nodules and hepatocellular carcinoma.

Authors:  Jun Sang Bae; Ha Na Choi; Sang Jae Noh; Byung Hyun Park; Kyu Yun Jang; Cheol Keun Park; Woo Sung Moon
Journal:  Oncol Lett       Date:  2012-05-25       Impact factor: 2.967

10.  Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma.

Authors:  Matteo Cescon; Matteo Ravaioli; Gian Luca Grazi; Giorgio Ercolani; Alessandro Cucchetti; Valentina Bertuzzo; Gaetano Vetrone; Massimo Del Gaudio; Marco Vivarelli; Antonietta D'Errico-Grigioni; Alessandro Dazzi; Paolo Di Gioia; Augusto Lauro; Antonio Daniele Pinna
Journal:  J Transplant       Date:  2010-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.